StockData
NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31

Niki BioSolutions, Inc.

Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026
$2.08+0.05 (+2.46%)

Close on Oct 19, 2026

Market cap
$16.66M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q3 FY2024
Ended Sep 30, 2024
Dec 20, 2024After market close–––
Q2 FY2022
Ended Jun 30, 2022
Sep 30, 2022After market close–––

Press releases

Announcements Niki BioSolutions filed with the SEC